Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice

Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice

Abstract This study tests the hypothesis that an Onchocerca volvulus vaccine, consisting of two recombinant antigens (Ov-103 and Ov-RAL-2) formulated with the combination-adjuvant Advax-2, can induce protective immunity in genetically diverse Collaborative Cross recombinant inbred intercross mice (C...

Full description

Bibliographic Details
Main Authors:	Nathan M. Ryan, Jessica A. Hess, Fernando Pardo-Manuel de Villena, Benjamin E. Leiby, Ayako Shimada, Lei Yu, Amir Yarmahmoodi, Nikolai Petrovsky, Bin Zhan, Maria Elena Bottazzi, Benjamin L. Makepeace, Sara Lustigman, David Abraham
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-01-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-020-00276-2

Similar Items

Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to <i>Onchocerca volvulus</i> in Mice and Non-Human Primates
by: Nathan M. Ryan, et al.
Published: (2023-07-01)

Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
by: Sara Lustigman, et al.
Published: (2007-08-01)

Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.
by: John B Patton, et al.
Published: (2018-12-01)

A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection.
by: Andy Alhassan, et al.
Published: (2014-01-01)

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
by: Shabnam Jawahar, et al.
Published: (2021-02-01)

The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
by: Fidelis Cho-Ngwa, et al.
Published: (2010-08-01)

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
by: Parakkal Jovvian George, et al.
Published: (2019-09-01)

The mitogenome of Onchocerca volvulus from the Brazilian Amazonia focus
by: James L Crainey, et al.
Published: (2016-01-01)

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
by: Beesan Tan, et al.
Published: (2022-03-01)

Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
by: Mike Y Osei-Atweneboana, et al.
Published: (2011-03-01)

Oligonucleotide based magnetic bead capture of Onchocerca volvulus DNA for PCR pool screening of vector black flies.
by: Hemavathi Gopal, et al.
Published: (2012-01-01)

Individual exposure to <it>Simulium bites and intensity of Onchocerca volvulus infection</it>
by: Enyong P, et al.
Published: (2010-06-01)

Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México.
by: Mario A Rodríguez-Pérez, et al.
Published: (2013-01-01)

Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon
by: Vera Wewer, et al.
Published: (2021-08-01)

Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
by: Rodrigo J Gonzalez, et al.
Published: (2009-01-01)

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.
by: Peter D Burbelo, et al.
Published: (2009-01-01)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
by: An Hotterbeekx, et al.
Published: (2020-02-01)

Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.
by: Narcisse V T Gandjui, et al.
Published: (2021-02-01)

Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus.
by: Christoph Malkmus, et al.
Published: (2020-11-01)

QTL mapping in new Arabidopsis thaliana advanced intercross-recombinant inbred lines.
by: Sureshkumar Balasubramanian, et al.
Published: (2009-01-01)

Comparison of structural changes in nodding syndrome and other epilepsies associated with Onchocerca volvulus
by: Mazumder, R, et al.
Published: (2022)

Comparison of Diagnostic Tests for <i>Onchocerca volvulus</i> in the Democratic Republic of Congo
by: An Hotterbeekx, et al.
Published: (2020-06-01)

Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulus
by: Samuel Armoo, et al.
Published: (2017-04-01)

The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
by: Lakwo Thomson Luroni, et al.
Published: (2017-01-01)

Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors.
by: Mary Doherty, et al.
Published: (2023-12-01)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
by: Bin Zhan, et al.
Published: (2022-04-01)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Colebunders, R, et al.
Published: (2021)

Nodding syndrome is unlikely to be an autoimmune reaction to leiomodin-1 after infection by Onchocerca volvulus
by: Kenneth G. Kodja, et al.
Published: (2023-09-01)

Macrofilaricidal effects of chloroquine on adult Onchocerca volvulus by local infiltration of palpable onchocercal nodules
by: Ronald H. Guderian, et al.
Published: (1997-12-01)

A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
by: Allison Golden, et al.
Published: (2016-01-01)

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
by: Robert Adamu Shey, et al.
Published: (2018-01-01)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Robert Colebunders, et al.
Published: (2021-01-01)

Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
by: Laura Senyonjo, et al.
Published: (2016-08-01)

A new set of BXD recombinant inbred lines from advanced intercross populations in mice
by: Gu Jing, et al.
Published: (2004-04-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
by: Alfred Dusabimana, et al.
Published: (2020-12-01)

Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination.
by: Himal Shrestha, et al.
Published: (2022-07-01)

Population dynamics of Onchocerca volvulus microfilariae in human host after six years of drug control
by: K.N. Opara, et al.
Published: (2008-02-01)

Is nodding syndrome an Onchocerca volvulus-induced neuroinflammatory disorder? Uganda's story of research in understanding the disease
by: Richard Idro, et al.
Published: (2016-04-01)

Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo
by: Francois Korbmacher, et al.
Published: (2018-05-01)

Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome.
by: Ole Lagatie, et al.
Published: (2017-01-01)